Achieve Life Sciences, Inc. (FRA:SP4P)

Market Cap	218.20M
Revenue (ttm)	n/a
Net Income (ttm)	-44.61M
Shares Out	n/a
EPS (ttm)	-1.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	396
Open	4.105
Previous Close	3.845
Day's Range	4.105 - 4.105
52-Week Range	1.732 - 4.515
Beta	n/a
RSI	57.14
Earnings Date	Mar 13, 2026

About Achieve Life Sciences

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

• Industry: Pharmaceutical Preparations
• CEO: Richard A. Stewart
• Employees: 25
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SP4P

Financial Performance

Financial numbers in USD